Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     Respiratory & Anesthesia Devices    

Global Respiratory therapeutic devices Market Research Report

Respiratory therapeutic devices and Sleep Apnea Devices, Respiratory monitoring devices, Respiratory diagnostic, Preterm respiratory care devices and Anesthesia devices adds up to total Respiratory & Anesthesia Devices market.

Respiratory therapeutic devices can be segmented by Geographies, Companies and Products. Geographies of this market are USA, Europe, Asia and Rest of World. Companies of this market are Covidien Plc, Philips Respironics, ResMed, GE Healthcare, Smiths Medical, Carefusion Corporation, Fisher and Paykel and B. Braun Melsungen AG. Products of this market are Respiratory Humidifiers, Nebulizer, Oxygen concentrators, Ventilators, Respiratory Inhalers, Reusable resuscitators and Positive Airway Pressure (PAP).

 

Key Questions Answered

  • What are market estimates and forecasts; which of Respiratory therapeutic devices markets are doing well and which are not?
  • What is the competitive landscape; How companies like Covidien Plc, Philips Respironics and ResMed doing in Respiratory therapeutic devices?
  •  

    What makes our report unique?

    • This report provides market sizing and forecast for the Respiratory therapeutic devices market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
    • The report provides deep dive competitive landscape covering the top players such as Covidien Plc, Philips Respironics, ResMed and GE Healthcare.
    • The reports provides benchmarking insight on the top players Covidien Plc, Philips Respironics, ResMed and GE Healthcare.
    • The report provide competitive intelligence on Covidien Plc, Philips Respironics, ResMed and GE Healthcare.
    •  

      Audience for this report

      • Global Respiratory therapeutic devices companies
      • Manufacturing Companies
      • Traders, distributors, and suppliers
      • Governmental and research organizations
      • Associations and industry bodies
      • Technology providers
      •  

        Top developments

        • Philips partnered with the Stockholm County Council and Karolinska University Hospital to meet future demands of health care
        • Philips partnered with the Stockholm County Council and Karolinska University Hospital to meet future demands of health care
        • Philips partnered with the Stockholm County Council and Karolinska University Hospital to meet future demands of health care
        • Philips partnered with the Stockholm County Council and Karolinska University Hospital to meet future demands of health care
        • Teleflex partnered with Intuitive Surgical to create access solutions for new da Vinci Xi Surgical System.
        • CareFusion Launched New AVAflex Vertebral Balloon System for Targeted Balloon Placement.
        • CareFusion Launched New AVAflex Vertebral Balloon System for Targeted Balloon Placement.
        • CareFusion Launched New AVAflex Vertebral Balloon System for Targeted Balloon Placement.
        • CareFusion Launched New AVAflex Vertebral Balloon System for Targeted Balloon Placement.
        • Teleflex launched the Rusch DispoLED Laryngoscope Handle.
show more
PRODUCT TITLE PUBLISHED
Positive Airway Pressure (PAP) Positive Airway Pressure (PAP)
The global Positive Airway Pressure (PAP) device market has gained tremendous importance owing to the large patient base of Obstructive Sleep Apnea (OSA). The market was valued at $4.7 billion in 2013 and is expected to reach a value of $10.4 billion in 2018, with a CAGR of 17.3% from 2013 to 2018. The market has been segmented on the basis of products, geographies, end users, companies, and macro indicators. A deep-dive analysis of the key players has been provided in this report.      
Upcoming
North American Positive Airway Pressure (PAP) North American Positive Airway Pressure (PAP)
The North American Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA) as it forms the first line of treatment used for Sleep Apnea. The market is clinched at $2.7 billion in 2013 and is expected to reach a value of $6.0 billion in 2018, with a CAGR of 17.23 from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Upcoming
2 of 2 items
2 reports | Show
Connect With Us
US/CAN : +1-888-502-0539
Respiratory therapeutic devices